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A DAIRY-BASED PROTEIN, CALCIUM AND VITAMIN D
SUPPLEMENT REDUCES FALLS AND FEMORAL NECK BONE LOSS
IN AGED CARE RESIDENTS: A CLUSTER RANDOMISED TRIAL
S. Iuliano-Burns1, J. Woods3, K. King2, A. Ghasem Zadeh1, X.-F. Wang1, Q. Wang1, E. Seeman1
Introduction
Falls and fractures are common in elderly persons
living in aged-care facilities, in part because of the higher
prevalence of co-morbidities, vitamin D deficiency and
bone fragility (1). Falls are the leading cause of injury,
disability and death in the elderly (2). About 30% of
people >65 years of age fall one or more times each year
(3). Over 30% of all hip fractures in the community arise
from residents in aged care facilities (4). Fracture rates are
higher in ambulatory low-level aged care residents than
those in nursing home so this is a high-risk group in
which targeting of therapies to reduce falls and fracture
risk is most cost effective (5).
Deficiencies of protein, calcium and vitamin D are
common in the elderly, and they increase fracture risk by
producing reduced muscle strength, impaired balance,
increased bone remodelling, bone loss and bone fragility
(6-8). Therefore correcting nutrient deficiencies is a
potentially useful approach to fracture prevention
because such a method is accessible to all persons, low
cost and free of adverse events.  
Hip fracture patients are often malnourished, and
protein supplementation improved serum IGF-1,
shortened recovery time and reduced complications (9,
10). Calcium and vitamin D supplementation reduced fall
frequency, bone remodelling and non-vertebral fractures
in institutionalised elderly women (11, 12). Poor
compliance with medications limits anti-fracture efficacy.
However, food fortification is a potential vehicle to
augment intakes, with a 12.3% decrease in PTH and a
16.9% increase in IGF-1 observed in elderly women after
1-month of supplementation using calcium and vitamin
D fortified cheese (13).
We conducted a randomised, single-blind facility-
based intervention in residents of low-level aged care
facilities to determine if a dairy-based protein, calcium
and vitamin D supplement that increases intakes of these
nutrients to recommended levels will reduce falls and
fracture risk in ambulatory aged-care residents.
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Abstract: Objectives: To test if a dairy-based protein (9g/d), calcium (600mg/d) and vitamin D (960IU/d) supplement formulated to
increase intakes to recommended levels would reduce falls and fracture risk in ambulatory low-level aged care residents. Design:
Cluster-randomised, single-blind intervention. Setting: 16 low-level aged care facilities in Melbourne, Australia. Participants: 813
residents (mean age 86.1 ± 5.9 years, 76% female). Intervention: 12 months of observation in all facilities followed by 8 months of
food-based supplementation (intervention) or usual intake (controls). Measurments: Number of fallers, and non-vertebral fractures,
serum 25(OH)D, PTH, osteocalcin, bone mineral density (BMD), bone structure and volumetric BMD at the distal radius and tibia
using high-resolution pQCT,  balance (Lord’s balance test) and functionality (timed up and go, walking velocity). Repeated
measures ANOVA and logistic regression models were used to compare cases and controls. Results: Among the whole sample,
supplementation reduced the number of fallers by 42% (OR = 0.58, 95% CI: 0.44 – 0.78, p < 0.001), Among the 58 participants with
follow up data, supplementation prevented bone loss at the proximal femur, maintained serum 25(OH)D and reduced PTH by 16%
± 8%, p < 0.03. Conclusion: Fortifying foods with protein, calcium and vitamin D reduced falls in ambulatory aged care residents
and is a widely accessible, and inexpensive approach to potentially reduce falls and slow the progression of bone fragility in the
elderly.   
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Methods
Twenty low-level (hostel) aged care facilities in
Melbourne, Australia, housing 1370 residents were
recruited, of which 16 facilities and 813 residents
completed the trial. These facilities are equivalent to
assisted care (USA) or residential care (UK) and were
selected due to their higher falls rates compared to
nursing home residents (14). All facilities are accredited
therefore comply with Federal Government standards for
care, provision of services, staffing requirements,
residents’ safety and facility layout.  Only accredited
facilities were recruited.  Admission into aged-care is
Government regulated so low-level residents have similar
health needs. High-care (nursing home) facilities were not
included in this study.  No other fall prevention strategies
were undertaken during the study.  Facilities were
stratified based on location (similar demographics) and
randomised to supplementation or control. The study
consisted of one-year of observation in all facilities to
establish baseline falls and fracture rates, followed by a
year of observation (controls), or 8 months of
supplementation (intervention) to ensure the supplement
was consumed prior to its “use-by” date. 
Twenty five percent of residents consented to having
their medical records reviewed that were maintained at
facilities (Figure 1).  84 residents (10.3%) consented to
undergo a full assessment (BMD, serum, strength and
functional measures) at baseline and 58 residents were
available at study completion.  Loss to follow up was due
to death (n=14) or transfer to high-care (n=12) (Figure 1).
Residents without follow up were similar To those who
completed the trial, however more were on vitamin D
supplements, so more were vitamin D replete (Table 1).
Those who failed to complete the trial tended to be males,
and have higher dietary vitamin D intakes (p=0.1) (Table
1).   Bone structure assessments (HR-pQCT) became
available after initial recruitment, so only the 84
consented residents were allowed to be approached, of
which 57 consented and were assessed at baseline.  Bone
structure data were available from 40 residents at trial
completion.  Loss to follow up was due to death (n=6),
transfer to high-care (n=3), illness (n=2), unavailability
(n=4), or refusal (n=2) (Figure 1). The human research
ethics committees of Austin Health and Monash
University approved the study.
Supplementation
The dairy based supplement consisted of whey protein
(Warrnambool Cheese and Butter Factory, Warrnambool,
Australia), calcium derived from milk minerals and
vitamin D3 (Murray Goulburn Co-op P/L, Brunswick,
Australia). The prescribed dose of 2 tablespoons/day
provided 9g protein, 600mg calcium and 960IU vitamin
D3, to increase mean intakes to recommended levels.
Food service staff were trained to incorporate the
supplement powder into foods, and were provided with
procedures manuals and on-site support. To aid
administration, the supplement was also combined into
30 different foods items (La Croissant Bakery,
Elsternwick, Australia) and provided to hostels weekly.
Two food products/day provided the prescribed dose.
Administration of the supplement was recorded using a
standardised recording sheet of product usage (powder
and fortified foods) and food delivery (pre-fortified
foods) at each hostel. Individual compliance was
monitored using 3-day weighed food records during and
at intervention end (total=6 days).  
Figure 1. Flow Chart For Elderly Aged Care Residents From 20
Aged Care Facilities Participating in a Cluster Randomised
Dairy Based Protein, Calcium and Vitamin D Intervention Trial. 
*BMD, serum, strength and functional measures
Assessments
Falls, defined as an event which results in a person
coming to rest inadvertently on the ground or other lower
level, were monitored in all 813 residents using a
standardised falls report sheet, that documented time,
location and outcome of fall (i.e. injury type) (15).  Data
was validated from incident reports, as reporting of falls
is mandatory in all facilities.  Fractures were verified from
hospital medical records. 
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Table 1
Baseline Characteristics of Elderly Low-Level Aged Care
Residents Assigned to Intervention or Control Group,
and a Comparison to Those Lost to Follow Up
Intervention Control P value Lost to
n=45 n=39 n=26 Follow Up
Age (yrs) 86.5±6.3 85.2±7.3 0.43 86.7±6.0
Males/Females (number) 13/32 7/32 0.19 9/17
Height (cm) 156.2±8.1 154.8±7.9 0.43 1.58.2±8.6
Weight (kg) 64.8±11.0 65.0±11.7 0.94 66.0±10.1
Lean (kg) 39.4±7.5 37.5±5.5 0.20 39.5±6.5
Fat (kg) 22.2±8.4 24.2±8.5 0.17 22.9±8.2
Medical conditions 5.4±0.3 4.9±0.3 0.33 5.3±2.7
Cardio-vascular (%) 33 53 0.35 48
Arthritis (%) 56 47 0.42 46
Depression (%) 26 28 0.86 17
Long term medications 9.9±0.6 9.0±0.7 0.34 9.9±4.9
Fracture history (%) 35 31 0.69 36
Vitamin D supplements (%) 35 32 0.64 50^
Calcium supplements (%) 26 32 0.60 33
Osteoporosis medication (%) 26 22 0.61 27
Serum 25(OH)D nmol/L 49.8±31.2 49.5±32.5 0.96 56±32
Vitamin D Status* (D/M/S) (%) 21/40/39 16/48/36 0.90 21/24/55^
Total Energy (kj/day) 5932±1719 6209±1245 0.76 6177±1293
Protein (g/day) 52±13 55±12 0.54 53±12
Calcium (mg/day) 537±165 548±149 0.82 591±256
Dietary Vitamin D (μg/day) 2.58±0.24 2.17±0.49 0.90 3.23±0.84
D=severe/moderate deficiency (<25nmol/L), M=mildly deficiency (25-
50nmol/L), S=sufficient (>50nmol/L) *based on Australian standards (40).
Conversion of serum 25(OH)D to ng/ml = (nmol/L)/2.5
^p<0.01, different to those who remained in trial
Total body, lumbar spine and proximal femur bone
mineral density (BMD), and body composition were
measured using DXA (Prodigy, Version 7.51, GE Lunar,
Madison, WI, CV=1%, inter-operator CV=2% determined
on 5 adults scanned 5 times).  Volumetric BMD and bone
structure were assessed at the distal tibia and distal
radius using 3-dimensional high-resolution peripheral
quantitative computed tomography (HR-pQCT),
(XtremeCT;Scanco Medical AG, Bassersdorf, Switzerland,
CV<0.6–7.4%). Morning fasting blood samples were
drawn before and at the end of supplementation and
analysed for serum 25(OH)D; chemiluminescent
immunoassay (CLIA) (Liason, DiaSorin, Stillwater, USA),
calcium; indirect potentiometry (SYNCHRON LX,
Beckman Coulter Inc. USA), parathyroid hormone (PTH);
CLIA (DPC Immulite 2000, Los Angeles, USA), albumin;
bichromatic digital endpoint (SYNCHRON DxC-800,
Beckman Coulter Inc. USA), N-Mid Osteocalcin (OC);
electrochemiluminescence immunoassay (Elecsys 1010
Analytics, Roche Diagnostics, Germany). The intra- and
inter-assay CV’s for serum measures were 7-13%.
Balance was assessed using the Lord’s balance test
measuring horizontal displacement at waist level over 30-
seconds (16). Muscle strength at the knee
(flexion/extension), ankle (dorsi/plantar flexion) and hip
(abduction/adduction) of both legs was assessed using
the Nicholas manual muscle tester (Lafayette
Instruments, Lafayette, IN, USA), with the mean of three
trials used (17).  Mobility was determined using the
timed ‘up and go’ (TUG) test and walking velocity over
6-meters (17, 18). The same researcher, blinded to group
allocation, performed all assessments.
Nutrient intake was evaluated before and twice during
supplementation (dietary+supplementary for
intervention group) using 3-day weighed records of all
foods, beverages, and food supplements served and
consumed at meals and snack times. A recall of items
consumed outside meal was taken. Foods were weighed
to ±1g on digital scales (Soehnle Venezia, Switzerland).
Mean daily nutrient intake was calculated using SERVE
Nutrition Management System version 5.0.012, 2004
(Serve Nutrition Systems, St Ives, Australia).  Vitamin D
intake was calculated using FoodWorks Professional
Edition, 2009 (XYRIS Software, Brisbane, Australia).
Statistics
Independent t-tests were used to determine group
differences at baseline. Repeated-measurement ANOVA
was used for analysing the effect of the intervention on
continuous variables or ANCOVA if group differences at
baseline were detected. Differences were annualised
[(post-pre)/time].  The effect of supplementation on
number of fallers was determined using logistic
regression models.  Based on falls frequencies during the
first year of observation, additional logistic regressions
were performed with residents categorised as non- (no
falls), infrequent- (1-2 falls) or frequent fallers (≥ 3 falls).  
Based on a annual decline in muscle strength of 2.4%,
prevention of this decline (0.0±3.6%) required 36
participants in each group, 28 were needed to detect a
3.0±4.0% difference in bone density and structure and 137
required to detect a 40% reduction in the number of
fallers with 80% power at p<0.05 (19-21).  Data were
presented as mean±SD unless stated otherwise.  P<0.05 is
considered statistically significant, but values p<0.1 are
reported.
Results
Data were obtained from 7 intervention and 9 control
facilities with loss to follow up due to facility closure
(n=1) or sale (n=3).  Falls data was available for 813 of
1370 residents (mean age 86.1±5.9 yrs, 75% females) with
loss to follow up in 557 residents due to death (46%),
transfer to high-care (33%), changed facilities (21%) or
discharge home (1%) (Figure 1).  A similar proportion
from both the intervention and control group failed to
complete the trial.  
Intervention and control groups were similar at
baseline (Table 1).  Of those who provided follow up
data, groups were similar in age, anthropometry and
medical histories (data not shown), but differences were
observed for total proximal femur BMD and TUG (Table
3).  
Supplementation maintained serum 25(OH)D (which
decreased in controls by 22±37%, p<0.01) and reduced
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PTH (-16%±8%, p<0.03) (Table 3). No group differences in
serum osteocalcin were observed (Table 3).  Mean daily
supplementation determined from weighed food intakes
was 4.4±1.2g protein, 298±78mg calcium and 474±125IU
vitaminD3.  Total calcium (537±165 v 802±258mg/day,
p<0.05) and vitamin D (2.58±0.24 v 13.62±3.73μg/day,
p<0.01) intakes but not protein intake (52±13 v
55±17g/day) increased with supplementation.  During
the supplementation period, calcium (802±258 v
615±297mg/day, p<0.05) and vitamin D (13.62±3.73 v
2.23±0.89μg/day, p<0.01) intakes were higher in the
intervention group compared to controls. 
Table 2
Falls and Fracture Incidence in Ambulatory Aged Care
Residents Before and After Supplementation With a
Dairy Based Protein, Calcium and Vitamin D Supplement
Intervention Controls
n=301 n=512
Year 1 Year 2 Year 1 Year 2
No. fallers (%) 158 (52.5) 113 (37.5) 233 (45.5) 260 (50.8)
1-2 falls 96 58 160 144
3+ falls 62 55 72 115
Total falls 594 478 749 1093
Mean falls (range) 2.0 (0-40) 1.6 (0-18) 1.4 (0-132) 2.1 (0-149)
Non-vertebral fractures (%) 4 (1.3) 5 (1.6) 9 (1.8) 10 (2.0)
The incidence of falls and fractures were similar in
both groups during the observation year (Table 2).
Supplementation was associated with a 42% reduction in
the number of fallers relative to controls (OR=0.58, 95%
CI:0.44–0.78, p<0.001).  Among those who did not fall in
the observation year, supplementation reduced the
number of fallers by 65% relative to controls (OR=0.35
95% CI:0.22–0.57, p<0.001).  For infrequent fallers (1-2
falls during the observation year), supplementation
reduced the number of fallers by 46% (OR=0.54 95%
CI:0.32–0.91, p<0.05).   However, for frequent fallers (3+
falls during the prior year), supplementation did not
reduce the number of fallers (OR=0.86, 95% CI:0.42–1.76,
p=0.68) (Figure 2).  For facilities that were supplemented
(n=7), there was a trend for a dose effect of
supplementation on falls reduction (r=-0.6, p=0.1) in that
higher supplement consumption was associated with
fewer fallers.  Fracture incidence (1-2%) remained
unchanged in both groups relative to the observation
period (Table 2).
Total proximal femur BMD remained unchanged with
supplementation but decreased by 2.5% in controls
(p<0.09 unadjusted and p<0.05 after adjustment for
baseline total proximal femur BMD).  No group
differences in spine BMD were observed (Table 3).  At the
distal tibia, trabecular bone volume fraction increased
with supplementation (p<0.05) (Table 3).  No group
differences were detected for measures at the distal
radius (data not shown). No group differences were
observed for balance, walking velocity, mobility or lean
mass (intervention 0.6±1.4kg v controls 0.2±1.0kg) (Table
3). 
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Table 3
Functional and Skeletal Changes Over Time in Supplemented and Non-Supplemented Elderly Aged Care Residents.
Mean ± SD
Intervention (n=31) Control (n=27)
Pre Post Difference Pre Post Difference
Strength (kg)
Knee (flexion/extension) 9.9±3.4 7.1±1.8 c -1.9±2.0 9.2±2.8 7.0±1.4 c -2.1±2.1
Hip (adduction / abduction) 11.2±4.1 9.9±2.6 -0.9±2.5 10.6±4.2 9.0±2.4 d -1.5±3.0
Ankle (dorsi / plantar flex.) 13.0±3.2 9.5±2.4 c -3.5±2.2 12.4±3.2 9.6±1.6 c -2.9±2.2
Function (sec)
Timed up & Go 13.8±5.0 e 16.2±10.2 1.6±4.5 17.0±7.7 14.2±5.0 -2.7±5.0
Velocity over 6m 9.7±3.5 10.1±3.8 0.3±1.7 9.0±2.4 9.3±3.3 0.3±2.4
Balance (mm of displacement)
Eyes open (EO) 52±42 59±58 5±44 33±33 29±23 -4±37
Eyes closed (EC) 59±79 46±54 -6±64 34±37 30±28 -4±37
EO on foam 31±18 42±75 8±37 26±25 23±13 -3±27
EC on foam 21±13 37±44 11±30 15±10 19±18 4±19
Densitometry-BMD (g/cm2)
Total prox. fem. region 0.74±0.13 f 0.74±0.13 -0.02±0.03 b* 0.67±0.07 0.63±0.12 -0.03±0.06
Lumbar spine (2-4) 1.16±0.22 1.19±0.25 0.02±0.04 1.08±0.12 1.07±0.19 - 0.01±0.05
HR-pQCT
Distal Tibia
Trab. vBMD (mg HA/cm 3) 161±44 164±44 3.1±2.4 a 156±53 156±52 0.3±2.2
- BV/TV fraction 0.14±0.04 0.14±0.04 -0.00±0.00 b 0.13±0.04 0.13±0.04 -0.00±0.00
- Number (1/mm) 2.2±0.5 2.2±0.5 0.1±0.2 2.0±0.7 2.0±0.7 -0.1±0.2
- Thickness (mm) 0.06±0.01 0.06±0.01 -0.00±0.01 0.07±0.03 0.07±0.03 0.00±0.01
Cort. vBMD (mg HA/cm 3) 657±139 651±128 -6±24 755±90 757±94 2±12
Serum markers
25(OH)D nmol/L*^ 37.6±23.0 51.4±38.7 13.7±40.4 a 49.9±33.6 38.5±26.8 c -11.4±16.3
PTH (pmol/L)* 9.6±6.8 7.8±5.4 -1.8±3.6 a 9.0±4.3 9.2±4.0 0.2±2.2 
Osteocalcin (ng/ml) 26.8±13.0 24.9±10.7 -1.2±6.7 35.3±27.6 34.7±28.3 -0.7±14.2
a. p<0.05, b. p<0.09, different to control (repeated measures ANOVA), * p<0.05 after adjustment for baseline differences; c. p<0.01, d p<0.05, different to baseline. e.
p<0.01, f p<0.05, group difference at baseline (unpaired t-test); Reference ranges: 25(0H)D; 75-250nmol/L, PTH 1.6-6.9pmol/L, osteocalcin 7.3–37.8 ng/ml (Post-
menopausal Caucasian women); ^ ng/ml = (nmol/L divided by 2.5).
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Figure 2. Odds Ratio (95% CI) for Risk of Falls During Year 2
(Supplementation Period) for Residents Receiving 8 months of
Supplementation Using a Dairy Based Supplement, Relative to
Non-supplemented Control Residents. OR are for All Residents
(n=813), and Expressed According to Falls History; Non-Fallers
(n=423),, Infrequent Fallers (1-2 falls per year, n=253) and
Frequent Fallers (3+ falls per year, n=137)
Discussion 
Among 813 residents in 16 aged-care facilities,
supplementation with protein, calcium and vitamin D
reduced the number of residents who fell by 42%.  The
benefit was confined to individuals with no or moderate
(1-2/yr) histories of falls.  Residents with a higher
incidence of falls did not benefit from supplementation.
Supplementation slowed bone loss at the proximal femur,
maintained serum 25(OH)D and reduced PTH.  No trials
of falls reduction in the elderly have examined the effects
of simultaneously supplementing with protein, calcium
and vitamin D.   
25(OH)D deficiency increases with age, therefore the
maintenance of 25(OH)D with supplementation may
have prevented detrimental changes in muscle and
physical function and the increase in falls risk associated
with vitamin D deficiency and ageing (22, 23).  Given the
low dietary vitamin D intakes in the residents, while the
level achieved prevented some loss of hip strength, levels
> 60 nmol/L may be required to improve physical
function (24). This would require higher doses of vitamin
D (25). 
Secondary hyperparathyroidism is associated with
increased bone remodelling and cortical bone loss (26).
Supplementation reduced serum PTH and slowed bone
loss at the proximal femur as reported using calcium plus
vitamin D therapy (27). The combined dose of calcium
and vitamin D, did improve total calcium and vitamin D
intakes and likely contributed to the reduction in PTH.  
400IU daily was effective in reducing wintertime
lumbar spine bone loss in postmenopausal women with
mean dietary vitamin D intakes of ~100IU/day (28).
Therefore the vitamin D dose received with
supplementation (474IU/day) likely contributed to the
slowing of bone loss.  This study was not powered to
detect fracture risk reduction (27). 
No benefits of supplementation were observed in
balance or physical function, perhaps because most
residents were mildly vitamin D deficient (25–50nmol/L).
The efficacy of vitamin D supplementation on physical
function in those with mild deficiency has not been
proven as no studies have been limited to those with
serum 25(OH)D levels between 25-50nmol/L (29).
However, improvements in body sway have been
observed after 8 weeks of vitamin D supplementation in
vitamin D deficient women (30). The small number of
residents with more severe vitamin D deficiency likely
limited the power to detect benefits of supplementation
on balance and physical function, and the dose received
was likely insufficient.  While the prescribed dose (960IU)
for this study was in line with recommendations to
reduce falls and improve physical function, the dose
received was less than levels in prior trials where benefits
to balance and physical function were observed (25). 
Lean mass was preserved and hip strength did not
significantly decline with supplementation.  Protein
deficiency is associated with reduced IGF-1 and lean
muscle mass however, few residents were protein
deficient (31).  Supplementation of older women with 15g
of essential amino acids increased IGF-1 expression, lean
muscle mass and muscle protein synthesis, and muscle
protein synthesis rates are enhanced by leucine from
whey protein (32, 33).  It has been suggested to maximise
muscle protein synthesis and prevent sarcopenia, larger
quantities (e.g. 25-30g) of high quality proteins are
consumed per meal (34).  The dose received in this trial
was below 25-30g, and distributed throughout the day
therefore may have only been sufficient to maintain but
not improve lean mass and only partially prevent a
decline in hip strength. 
An increase in trabecular vBMD was observed at the
distal tibia with supplemented group.  However, the
basis for this observation cannot be confirmed as current
methods of assessing trabecular architecture using high-
resolution pQCT are unable to distinguish between
cortical bone that has become trabecularized, from
trabecular bone of growth-plate origin (35). 
This study had a number of limitations.  The high staff
turnover (>70%) contributed to the administered
supplement dose being less than prescribed, because
supplement delivery was reliant on food service staff.
The powder required mixing prior to incorporation into
foods (e.g. sauces, desserts) to ensure the prescribed dose
was consumed. This task proved difficult for staff with
limited expertise in food preparation, and high work
demands. The provision of pre-fortified foods helped
overcome these issues, as staff did not require specific
skills or preparation time to administer supplemented
foods. Staff favoured food-fortification as it had minimal
impact on food service operations.
Food fortification has been used to successfully
JOURNAL OF AGING RESEARCH AND CLINICAL PRACTICE©
5
IULIANO_04 LORD_c  23/01/12  08:58  Page5
supplement aged care residents (13).  Food fortification is
practical as it does not require food intake to increase,
and compliance is good as food waste is ~5% (36).   The
95% consumption of the supplement in this trial was
higher than trials using tablet forms during which 1/3 of
residents consumed <75% of medications provided (37).
Despite the moderate supplement dose, modest benefits
were observed.  Future trials of food fortification should
be encouraged that incorporate higher doses of protein
and vitamin D as a safe and cost effective means of
addressing common nutritional deficiencies in
institutionalized elderly.
Attrition in this elderly population was high and
reduced the numbers available for follow-up resulting in
diminished power to detect differences.   Therefore to
retain adequate power, sample sizes need to be larger to
account for potential attrition rates >20%/year.  Higher
doses of protein and vitamin D would likely improve
efficacy. Cluster randomisation (randomised by hostel
not individual) was unlikely to have altered results as it
accounts for ~0.4% of the variance of falls-related
outcomes (38).
Falls and fractures increase morbidity and mortality
and result in long-term nursing care and high costs to the
community. Preventing falls and falls related injuries in
hostel residents and maintaining residents at this level of
care is cost effective as the cost of nursing home care is
approximately three times that of low level hostel care
(39).  Food fortification is potentially a feasible, effective
means of improving nutritional intake and reducing falls
in ambulatory aged care residents.
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